Home/Filings/4/0001437749-23-006009
4//SEC Filing

Lisjak Michael Eric 4

Accession 0001437749-23-006009

CIK 0000922247other

Filed

Mar 8, 7:00 PM ET

Accepted

Mar 9, 5:11 PM ET

Size

5.1 KB

Accession

0001437749-23-006009

Insider Transaction Report

Form 4
Period: 2023-03-07
Lisjak Michael Eric
Chief Regulatory Officer
Transactions
  • Award

    Stock Option (Right to buy)

    2023-03-07+41,03641,036 total
    Exercise: $1.28Exp: 2033-03-07Common Stock (41,036 underlying)
Footnotes (1)
  • [F1]The option vests over a four year period in equal monthly installments.

Issuer

Cyclo Therapeutics, Inc.

CIK 0000922247

Entity typeother

Related Parties

1
  • filerCIK 0001825761

Filing Metadata

Form type
4
Filed
Mar 8, 7:00 PM ET
Accepted
Mar 9, 5:11 PM ET
Size
5.1 KB